The Prognostic Quality of Risk Prediction Models to Assess the Individual Breast Cancer Risk in Women: An Overview of Reviews
Authors:
Open Access
- 21 March 2024
- journal article
- review article
- Published by Wiley in The Breast Journal
- Vol. 2024, 1-12
Abstract
Purpose. Breast cancer is the most common cancer among women globally, with an incidence of approximately two million cases in 2018. Organised age-based breast cancer screening programs were established worldwide to detect breast cancer earlier and to reduce mortality. Currently, there is substantial anticipation regarding risk-adjusted screening programs, considering various risk factors in addition to age. The present study investigated the discriminatory accuracy of breast cancer risk prediction models and whether they suit risk-based screening programs. Methods. Following the PICO scheme, we conducted an overview of reviews and systematically searched four databases. All methodological steps, including the literature selection, data extraction and synthesis, and the quality appraisal were conducted following the 4-eyes principle. For the quality assessment, the AMSTAR 2 tool was used. Results. We included eight systematic reviews out of 833 hits based on the prespecified inclusion criteria. The eight systematic reviews comprised ninety-nine primary studies that were also considered for the data analysis. Three systematic reviews were assessed as having a high risk of bias, while the others were rated with a moderate or low risk of bias. Most identified breast cancer risk prediction models showed a low prognostic quality. Adding breast density and genetic information as risk factors only moderately improved the models discriminatory accuracy. Conclusion. All breast cancer risk prediction models published to date show a limited ability to predict the individual breast cancer risk in women. Hence, it is too early to implement them in national breast cancer screening programs. Relevant randomised controlled trials about the benefit-harm ratio of risk-adjusted breast cancer screening programs compared to conventional age-based programs need to be awaited.Keywords
This publication has 63 references indexed in Scilit:
- Breast Cancer TreatmentJAMA, 2019
- Individualisiertes Brustkrebsrisiko – wie berechnen, wie bewerten und wie besprechen?Der Gynäkologe, 2018
- Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk PredictionJAMA Oncology, 2018
- Breast Cancer Screening for Women at Average RiskJAMA, 2015
- Benefits and Harms of Breast Cancer ScreeningJAMA, 2015
- Quantifying the Benefits and Harms of Screening MammographyJAMA Internal Medicine, 2014
- A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese populationBreast Cancer Research and Treatment, 2011
- Risk prediction models of breast cancer: a systematic review of model performancesBreast Cancer Research and Treatment, 2011
- A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performanceBreast Cancer Research and Treatment, 2011
- Breast cancer risk assessment in women aged 70 and olderBreast Cancer Research and Treatment, 2011